| A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020 | 1190 | 2020 |
| MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease Gastroenterology 158 (7), 1999-2014.e1., 2020 | 1100 | 2020 |
| Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ... Hepatology 69 (6), 2672-2682, 2019 | 744 | 2019 |
| Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ... PLoS medicine 11 (7), e1001680, 2014 | 555 | 2014 |
| Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ... Clinical Gastroenterology and Hepatology 17 (4), 748-755. e3, 2019 | 414 | 2019 |
| Apoptosis: why and how does it occur in biology? E Ulukaya, C Acilan, Y Yilmaz Cell biochemistry and function 29 (6), 468-480, 2011 | 267 | 2011 |
| is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions? Y Yilmaz Alimentary pharmacology & therapeutics 36 (9), 815-823, 2012 | 245 | 2012 |
| FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation … PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ... The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020 | 221 | 2020 |
| Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, S Aker, ... World journal of gastroenterology: WJG 13 (6), 837, 2007 | 213 | 2007 |
| The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease M Eslam, SK Sarin, VWS Wong, JG Fan, T Kawaguchi, SH Ahn, ... Hepatology international 14 (6), 889-919, 2020 | 212 | 2020 |
| Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease Y Yilmaz, F Eren, O Yonal, R Kurt, B Aktas, CA Celikel, O Ozdogan, ... European journal of clinical investigation 40 (10), 887-892, 2010 | 193 | 2010 |
| Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease Y Yilmaz, O Yonal, R Kurt, YO Alahdab, F Eren, O Ozdogan, CA Celikel, ... Scandinavian journal of gastroenterology 46 (1), 91-97, 2011 | 143 | 2011 |
| Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis Y Yilmaz, O Yonal, O Deyneli, CA Celikel, C Kalayci, DG Duman Acta Gastro Enterol. Belg 75, 240-244, 2012 | 134 | 2012 |
| Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year … I Akdag, Y Yilmaz, S Kahvecioglu, N Bolca, I Ercan, A Ersoy, M Gullulu Nephron Clinical Practice 108 (2), c99-c105, 2008 | 121 | 2008 |
| Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic … Y Yilmaz, RK Oya Yonal, M Bayrak, B Aktas, O Ozdogan Hepatitis monthly 11 (2), 103, 2011 | 113 | 2011 |
| Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis Y Yilmaz, YO Alahdab, O Yonal, R Kurt, AE Kedrah, CA Celikel, ... Metabolism 59 (9), 1327-1330, 2010 | 111 | 2010 |
| Systematic review: caspase‐cleaved fragments of cytokeratin 18–the promises and challenges of a biomarker for chronic liver disease Y Yilmaz Alimentary pharmacology & therapeutics 30 (11‐12), 1103-1109, 2009 | 110 | 2009 |
| Assessment of endothelial function in patients with nonalcoholic fatty liver disease Y Colak, E Senates, A Yesil, Y Yilmaz, O Ozturk, L Doganay, ... Endocrine 43 (1), 100-107, 2013 | 107 | 2013 |
| Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori O Bekar, Y Yilmaz, M Gulten Journal of medicinal food 14 (4), 344-347, 2011 | 107 | 2011 |
| Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease B Aktas, Y Yilmaz, F Eren, O Yonal, R Kurt, YO Alahdab, CA Celikel, ... Metabolism 60 (4), 544-549, 2011 | 104 | 2011 |
